Stanley Druckenmiller Abbott Laboratories Transaction History

Duquesne Family Office LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $60.6 Million - $77.5 Million	-791,300 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $7.85 Million - $11.5 Million	-125,000 Reduced 13.64%	791,300 $62.4 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $38.2 Million - $44.5 Million	-523,900 Reduced 36.38%	916,300 $77.1 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $9.57 Million - $11.6 Million	144,500 Added 11.15%	1,440,200 $115 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $36.9 Million - $41.9 Million	563,600 Added 76.98%	1,295,700 $93.7 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $44.5 Million - $53.7 Million	732,100 New	732,100 $53.7 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Duquesne Family Office LLC, based on Form 13F filings with the SEC.

Stay updated on Duquesne Family Office LLC and Stanley Druckenmiller with notifications on news.